Literature DB >> 24574321

Click hybridization of immune cells and polyamidoamine dendrimers.

Leyuan Xu1, Olga Yu Zolotarskaya, W Andrew Yeudall, Hu Yang.   

Abstract

Immobilizing highly branched polyamidoamine (PAMAM) dendrimers to the cell surface represents an innovative method of enhancing cell surface loading capacity to deliver therapeutic and imaging agents. In this work, hybridized immune cells, that is, macrophage RAW264.7 (RAW), with PAMAM dendrimer G4.0 (DEN) on the basis of bioorthogonal chemistry are clicked. Efficient and selective cell surface immobilization of dendrimers is confirmed by confocal microscopy. Viability and motility of RAW-DEN hybrids remain the same as untreated RAW cells according to WST-1 assay and wound closure assay. Furthermore, Western blot analysis reveals that there are no significant alterations in the expression levels of signaling molecules AKT, p38, and NFκB (p65) and their corresponding activated (phosphorylated) forms in RAW cells treated with azido sugar and dendrimer, indicating that the hybridization process neither induced cell stress response nor altered normal signaling pathways. Taken together, this work shows the feasibility of applying bioorthogonal chemistry to create cell-nanoparticle hybrids and demonstrates the noninvasiveness of this cell surface engineering approach.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bioorthogonal chemistry; cell surface engineering; dendrimers; drug delivery; imaging

Mesh:

Substances:

Year:  2014        PMID: 24574321      PMCID: PMC4133313          DOI: 10.1002/adhm.201300515

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  56 in total

Review 1.  Small-scale systems for in vivo drug delivery.

Authors:  David A LaVan; Terry McGuire; Robert Langer
Journal:  Nat Biotechnol       Date:  2003-10       Impact factor: 54.908

Review 2.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 3.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

4.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

Review 5.  What is nanomedicine?

Authors:  Robert A Freitas
Journal:  Nanomedicine       Date:  2005-03       Impact factor: 5.307

6.  Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines.

Authors:  Aristarchos Papagiannaros; Kostas Dimas; George Th Papaioannou; Costas Demetzos
Journal:  Int J Pharm       Date:  2005-09-30       Impact factor: 5.875

7.  Transbuccal Delivery of CNS Therapeutic Nanoparticles: Synthesis, Characterization, and In Vitro Permeation Studies.

Authors:  Quan Yuan; Yao Fu; Weiyuan John Kao; Damir Janigro; Hu Yang
Journal:  ACS Chem Neurosci       Date:  2011-11-16       Impact factor: 4.418

8.  Surface engineering of living myoblasts via selective periodate oxidation.

Authors:  P A De Bank; B Kellam; D A Kendall; K M Shakesheff
Journal:  Biotechnol Bioeng       Date:  2003-03-30       Impact factor: 4.530

9.  Metabolic labeling of fucosylated glycans in developing zebrafish.

Authors:  Karen W Dehnert; Brendan J Beahm; Thinh T Huynh; Jeremy M Baskin; Scott T Laughlin; Wei Wang; Peng Wu; Sharon L Amacher; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2011-04-05       Impact factor: 5.100

10.  In vivo imaging of Caenorhabditis elegans glycans.

Authors:  Scott T Laughlin; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2009-12-18       Impact factor: 5.100

View more
  11 in total

1.  In Situ-Forming Polyamidoamine Dendrimer Hydrogels with Tunable Properties Prepared via Aza-Michael Addition Reaction.

Authors:  Juan Wang; Hongliang He; Remy C Cooper; Hu Yang
Journal:  ACS Appl Mater Interfaces       Date:  2017-03-15       Impact factor: 9.229

2.  Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells.

Authors:  Leyuan Xu; Shannon Kittrell; W Andrew Yeudall; Hu Yang
Journal:  Nanomedicine (Lond)       Date:  2016-10-26       Impact factor: 5.307

3.  Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.

Authors:  Leyuan Xu; Remy C Cooper; Juan Wang; W Andrew Yeudall; Hu Yang
Journal:  ACS Biomater Sci Eng       Date:  2017-06-21

4.  The effect of photoinitiators on intracellular AKT signaling pathway in tissue engineering application.

Authors:  Leyuan Xu; Natasha Sheybani; W Andrew Yeudall; Hu Yang
Journal:  Biomater Sci       Date:  2015-02       Impact factor: 6.843

5.  Design strategies and applications of circulating cell-mediated drug delivery systems.

Authors:  Yixue Su; Zhiwei Xie; Gloria B Kim; Cheng Dong; Jian Yang
Journal:  ACS Biomater Sci Eng       Date:  2015-03-12

Review 6.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

Review 7.  Cell-based carrier for targeted hitchhiking delivery.

Authors:  Tonggong Liu; Cheng Gao; Dayong Gu; Huanwen Tang
Journal:  Drug Deliv Transl Res       Date:  2022-05-02       Impact factor: 5.671

8.  Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.

Authors:  Hongliang He; Chunqing Guo; Jing Wang; William J Korzun; Xiang-Yang Wang; Shobha Ghosh; Hu Yang
Journal:  Nano Lett       Date:  2018-09-17       Impact factor: 11.189

9.  Mildly Cross-Linked Dendrimer Hydrogel Prepared via Aza-Michael Addition Reaction for Topical Brimonidine Delivery.

Authors:  Juan Wang; Geoffrey S Williamson; Michael G Lancina Iii; Hu Yang
Journal:  J Biomed Nanotechnol       Date:  2017-12       Impact factor: 4.099

Review 10.  Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.

Authors:  Hu Yang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.